Clinical Trial Update: A Trial of Conversion Treatment of HAIC Combined With Camrelizumab and Apatinib for Unresected Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating hepatic arterial infusion chemotherapy with camrelizumab and apatinib for unresected hepatocellular carcinoma; status currentl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Apatinib (apatinib)
• Camrelizumab (camrelizumab)
• HAIC (hepatic artery infusion chemotherapy)

Snippet

Sponsor: Shandong Cancer Hospital and Institute | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN